The chairman of Singapore’s Medical Technology Industry Group, Albert Lee discusses the association’s key priorities, how they serve to advance the interests of both multinational and local members, and the key challenges that the medtech industry faces in transition from product-based to solutions-based care.
Can you provide an overview of the organization’s functional activities in Singapore, as well as describe how its scope has evolved alongside the country’s own development?
"The challenge is that potentially we may be spreading ourselves too thin, but when we look at the ecosystem, we can’t look at the healthcare system in segmented groups, as it is a whole value chain, and complex as it is."
